Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Narrative) (Details)

v3.23.3
Stockholders' Equity (Narrative) (Details)
 3 Months Ended
Oct. 01, 2023
shares
Oct. 07, 2022
May 09, 2022
USD ($)
$ / shares
shares
Oct. 31, 2021
$ / shares
Feb. 23, 2017
USD ($)
shares
Sep. 30, 2023
$ / shares
shares
Aug. 04, 2023
$ / shares
shares
Aug. 03, 2023
$ / shares
Jun. 30, 2023
$ / shares
shares
Dec. 06, 2022
shares
Jul. 19, 2022
shares
Nov. 01, 2021
$ / shares
shares
Dec. 09, 2020
shares
Stockholders' Equity [Line Items]                          
Preferred Stock, shares authorized           1,000,000     1,000,000        
Preferred stock, shares outstanding (in shares)           0     0        
Preferred stock, par value (in dollars per share) | $ / shares           $ 0.001     $ 0.001        
Common stock, shares authorized (in shares)           275,000,000     275,000,000        
Stockholders' Equity Note, Stock Split, Conversion Ratio   0.04                      
College Station Investors LLC And Bryan Capital [Member]                          
Stockholders' Equity [Line Items]                          
Warrants, exercise price per share | $ / shares                       $ 33.25  
Warrants to purchase shares of Common Stock                       51,583  
H.C. Wainwright & Co., LLC [Member]                          
Stockholders' Equity [Line Items]                          
Exercise of warrants (in shares)           0              
Warrants to purchase shares of Common Stock                   201,923      
Pre Funded Warrants [Member] | H.C. Wainwright & Co., LLC [Member]                          
Stockholders' Equity [Line Items]                          
Warrants, exercise price per share | $ / shares           $ 0.001              
Series A warrants                          
Stockholders' Equity [Line Items]                          
Warrants, exercise price per share | $ / shares             $ 0.50 $ 1.04          
Warrants to purchase shares of Common Stock             3,475,916            
Series A warrants | H.C. Wainwright & Co., LLC [Member]                          
Stockholders' Equity [Line Items]                          
Warrants, exercise price per share | $ / shares           $ 1.04              
Term of the warrants           5 years              
Warrants to purchase shares of Common Stock                   504,807      
Series B warrants                          
Stockholders' Equity [Line Items]                          
Warrants, exercise price per share | $ / shares             $ 0.50 $ 1.04          
Warrants to purchase shares of Common Stock             2,058,000            
Series B warrants | H.C. Wainwright & Co., LLC [Member]                          
Stockholders' Equity [Line Items]                          
Warrants, exercise price per share | $ / shares           $ 1.04              
Term of the warrants           2 years              
Warrants to purchase shares of Common Stock                   504,807      
Representative Warrants [Member] | H.C. Wainwright & Co., LLC [Member]                          
Stockholders' Equity [Line Items]                          
Warrants, exercise price per share | $ / shares           $ 1.30              
Term of the warrants           5 years              
iBio CMO Preferred Tracking Stock [Member]                          
Stockholders' Equity [Line Items]                          
Preferred Stock, Dividend Rate, Percentage         2.00%                
Preferred Stock, Dividends Per Share, Declared | $ / shares       $ 0                  
Preferred stock, shares outstanding (in shares)                       0  
Series 2022 Convertible Preferred Stock [Member]                          
Stockholders' Equity [Line Items]                          
Proceeds from sale of shares, net of issuance cost | $     $ 270                    
Shares issued upon conversion                     40    
Preferred stock, par value (in dollars per share) | $ / shares     $ 0.001                    
Shares issued     1,000                    
Stockholders' Equity Note, Stock Split, Conversion Ratio     1                    
Restricted Stock Units [Member]                          
Stockholders' Equity [Line Items]                          
Shares vested           89,403              
2020 Omnibus Equity Incentive Plan [Member]                          
Stockholders' Equity [Line Items]                          
Number of shares reserved for future issuance           906,762             1,280,000
Shares available for grant under the plan           65,918              
Exchange Agreement [Member] | iBio CMO Preferred Tracking Stock [Member] | Bioprocessing (iBio CDMO) [Member]                          
Stockholders' Equity [Line Items]                          
Stock Issued During Period, Shares, Acquisitions         1                
Number of LLC interest units exchanged for each share of preferred tracking stock         29,990,000                
Proceeds from sale of shares, net of issuance cost | $         $ 13,000,000                
Exchange Agreement [Member] | iBio CMO Preferred Tracking Stock [Member] | After Preferred Tracking Stock Exchanged for Units of Limited Liability Company Interests [Member] | Bioprocessing (iBio CDMO) [Member]                          
Stockholders' Equity [Line Items]                          
Noncontrolling Interest, Ownership Percentage by Parent         99.99%                
Exchange Agreement [Member] | iBio CMO Preferred Tracking Stock [Member] | Eastern Affiliate [Member] | After Preferred Tracking Stock Exchanged for Units of Limited Liability Company Interests [Member] | Bioprocessing (iBio CDMO) [Member]                          
Stockholders' Equity [Line Items]                          
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners         0.01%                
Lincoln Park Purchase Agreement [Member]                          
Stockholders' Equity [Line Items]                          
Shares issued 429,164         3,622,834